Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
News
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/63/d1/61/63d16168-b301-16c0-3d20-c2a264e6ad3c/mza_8949021004784125542.jpg/600x600bb.jpg
The Emerging Biotech Leader
SSI Strategy
57 episodes
17 hours ago
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
Show more...
Business
Science,
Life Sciences
RSS
All content for The Emerging Biotech Leader is the property of SSI Strategy and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
Show more...
Business
Science,
Life Sciences
https://img.transistor.fm/G_NEN4SVHVcWmqGAt9fPqRipfd1yEML5MTss7i8BPeE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81N2Uw/OWZmNjg5NmI2YTc0/Njk4YmZmY2QwMWZi/MjdlNi5qcGc.jpg
From Vision to Viability: The Decisions That Define a Biotech
The Emerging Biotech Leader
23 minutes
4 months ago
From Vision to Viability: The Decisions That Define a Biotech

What does it really take to launch a biotech company that lasts? In this episode, host Kim Kushner sits down with Dr. Marcia de Souza Lima, a physician-executive whose journey spans clinical care, global pharma, investment, and startup leadership. Together, they explore the earliest days of company formation—where every decision, from team design to product development, can shape the long-term path of the organization. 

The conversation begins with a familiar framework—the “Five P’s” of early biotech building: Product, People, Patents, Pennies, and Place. But Marcia challenges the idea that these alone are enough. She offers a fresh perspective on what leaders often overlook in the rush to build: the patient voice, the real-world context, and the flexibility to adapt as markets, teams, and therapies evolve. 

This Conversation Highlights: 

  • Why scientific novelty isn’t enough—your product must be positioned to matter. 
  • How to think about the patient perspective even before your first clinical milestone. 
  • Ways to balance scientific rigor with entrepreneurial speed in a resource-constrained environment. 
  • The talent trade-offs of hybrid vs. in-person teams—and how agility may be your biggest asset. 
  • The role of mentorship, curiosity, and asking the right questions—especially when you're doing this for the first time. 

Rather than presenting a checklist, this episode invites biotech leaders to think more holistically: How do you build something both scientifically sound and human-centered? How do you grow fast—without missing the fundamentals? 

If you're leading (or planning to lead) in biotech, this is a conversation that helps you zoom out, refocus, and reconsider what should come first. 

The Emerging Biotech Leader
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.